Question: Our physician is treating a patient for lung cancer. The patient has no brain secondaries and was administered prophylactic treatment for the brain. This was previously reported as brain cancer. Is it correct? What can be the correct codes for the brain treatment when the patient actually is receiving only prophylactic therapy?
North Dakota Subscriber
Answer: It is incorrect to report the brain malignancy in this situation. The brain cancer potential as a secondary malignancy to lung cancer cannot be reported as an assumption.
In diagnosis coding issues like this, you should report a diagnosis code 162.X (Malignant neoplasm of trachea bronchus and lung) for the ongoing treatment to the lung for lung cancer, with a fourth digit (162.0-162.9) that specifies the location in the lung. Make sure that you code the diagnosis to the highest degree of specificity, i.e., the exact location within the lung the physician is treating.
You may face a challenge while asking for reimbursement in prophylactic treatments. As a general rule, payers provide payment for the treatment of malignancies with radiation therapy. Malignancy is defined as behavior of a life-threatening manner, which includes diagnoses in addition to cancer but does not necessarily include prophylactic treatment. Based on the narrative of the case described, it does not demonstrate this kind of necessity for the brain treatment.
Although a specific ICD-9-CM code exists for prophylactic chemotherapy (V07.31, Need for prophylactic fluoride administration), the code for prophylactic radiation therapy would be assigned to V07.8 (Other specified prophylactic or treatment measure). A secondary diagnosis of V58.0 (Radiotherapy) would be appropriate. The diagnosis of primary lung cancer is the tertiary diagnosis for this treatment.
As authoritative guidance, the American Hospital Association, the entity responsible for maintaining the ICD-9-CM, publishes physician and outpatient coding guidelines. Relevant guidelines that apply to this situation include the following: